Agenus Inc., a medical-phase biotechnology business, discovers and develops therapies to activate the human body's immune program in opposition to most cancers and infections in The us and internationally. It provides Retrocyte Exhibit, an antibody expression platform for that identification of fully human and humanized monoclonal antibodies; and S